← Back
Data updated: Mar 10, 2026
CARACO
Neurology
CARACO is a generic drug manufacturer focused on Neurology.
1976
Since
5
Drugs
-
Trials
194
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-08
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2026-01-08
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2025-12-31
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (4)
Company Info
- First Approval
- 1976-09-03
- Latest
- 2008-12-23
- Applications
- 6